Is the SPINK1 variant p.N34S overrepresented in patients with acute pancreatitis?

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 3, 2012, Pages 309-315

  Jøergensen, Maiken Thyregod ^a   Brusgaard, Klaus ^a   Novovic, Srdan ^c   Andersen, Anders Møller ^c   Hansen, Mark Berner ^c,d   Gerdes, Anne Marie ^a,b   De Muckadell, Ove Bent Schaffalitzky ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Acute pancreatitis; C reactive protein; meta analysis.; p.N34S; p.P55S; SPINK1 variants

Indexed keywords

SERINE PROTEASE INHIBITOR KAZAL TYPE 1; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREATITIS; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATITIS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84856753046     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834ee5e2     Document Type: Article

References (34)

1. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathicchronic pancreatitis. Gastroenterology 2000; 119: 615-623.
2. Kazal LA. The metabolism of Pseudomonas fluorescens as interpreted by the relationship between metabolic end products and the electrical conductivity of the culture medium. J Bacteriol 1943; 45: 277-292.
3. Shibata T, Ogawa M, Matsuda K, Miyauchi K, Yamamoto T, Mori T. Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa. Clin Chim Acta 1986; 159: 27-36. (Pubitemid 16033053)
4. Shibata T, Ogawa M, Takata N, Matsuda K, Niinobu T, Uda K, et al. Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa. Res Commun Chem Pathol Pharmacol 1987; 55:243-248. (Pubitemid 17030102)
5. Marchbank T, Freeman TC, Playford RJ. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair. Digestion 1998; 59:167-174. (Pubitemid 28246384)
6. Bartelt DC, Shapanka R, Greene LJ. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys 1977; 179: 189-199. (Pubitemid 8047928)
7. Rinderknecht H. Pancreatic secretory enzymes. In: Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, editors. The pancreas: biology, pathology and disease. New York: Raven. 1993; pp. 219-251.
8. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25:213-216. (Pubitemid 30394996)
9. Threadgold J, Greenhalf W, Ellis I, Howes N, Lerch MM, Simon P, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002; 50:675-681. (Pubitemid 34407496)
10. Witt H, Luck W, Becker M, Bohmig M, Kage A,Truninger K, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001; 285:2716-2717. (Pubitemid 32525366)
11. Drenth JP, te MR, Jansen JB. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002; 50: 687-692. (Pubitemid 34407498)
12. Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, Laudanna AA, et al. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. JOP 2003; 4: 169-1 77. (Pubitemid 38963777)
13. Gomez-Lira M, Bonamini D, Castellani C, Unis L, Cavallini G, Assael BM, et al. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet 2003; 11:543-546. (Pubitemid 36896583)
14. Teich N, Schulz HU, Witt H, Bohmig M, Keim V. N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer. Pancreatology 2003; 3:67-68. (Pubitemid 36351181)
15. Lempinen M, Paju A, Kemppainen E, Smura T, Kylänpää ML, Nevanlinna H, et al. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 2005; 40:225-230. (Pubitemid 40189003)
16. Schneider A, Pfutzer RH, Barmada MM, Slivka A, Martin J, Whitcomb DC Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci 2003; 48:1110-1115. (Pubitemid 36667835)
17. Perri F, Piepoli A, Andriulli A. On the role of CFTR, PSSR1 and PST1/ SPINK1 in idiopathic chronic pancreatitis. Eur J Hum Genet 2003; 11: 107-108. (Pubitemid 36372382)
18. Diaconu BL, Ciobanu L, Mocan T, Pfützer RH, Scafaru MP, Acalovschi M, et al. Investigation of the SPINK1 N34S mutation in Romanian patients with alcoholic chronic pancreatitis. A clinical analysis based on the criteria of the M-ANNHEIM classification. J Gastrointest Liver Dis 2009; 18: 143-150.
19. O'Reilly DA, Witt H, Rahman SH, Schulz HU, Sargen K, Kage A, et al. The SPINK1 N34S variant is associated with acute pancreatitis. Eur J Gastroenterol Hepatol 2008; 20:726-731.
20. Aoun E, Muddana V, Papachristou GI, Whitcomb DC SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am J Gastroenterol 2010; 105:446-451, [Epub 3 November 2009].
21. Tukiainen E, Kylänpää ML, Kemppainen E, Nevanlinna H, Paju A, Repo H, et al. Pancreatic secretory trypsin inhibitor (SPINK1) gene mutations in patients with acute pancreatitis. Pancreas 2005; 30:239-242. (Pubitemid 40397375)
22. Bagul A, Pushpakom S, Balachander S, Newman WG, Siriwardena A. The SPINK1 N34S variant is associated with acute pancreatitis. Eur J Gastroenterol Hepatol 2009; 21:485.
23. Kuwata K, Hirota M, Sugita H, Kai M, Hayashi N, Nakamura M, et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol 2001; 36:612-61 8. (Pubitemid 32962809)
24. Kume K, Masamune A, Mizutamari H, Kaneko K, Kikuta K, Satoh M, et al. Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology 2005; 5:354-360, [Epub 23 June 2005]. (Pubitemid 41160272)
25. Masamune A, Ariga H, Kume K, Kakuta Y, Satoh K, Satoh A, Shimosegawa T. Genetic background is different between sentinel and recurrent acute pancreatitis. J Gastroenterol Hepatol 2011; 26:974-978.
26. Masamune A, Kume K, Shimosegawa T. Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis. J Gastroenterol 2007; 42 (Suppl 17):135-140. (Pubitemid 46140381)
27. Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, Yeo CJ, et al. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther 2003; 2:652-655.
28. UK Working Party on Acute Pancreatitis. United Kingdom guidelines for the management of acute pancreatitis. Gut 2005; 54:1-9.
29. Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002; 17 (Suppl):S15-S39. (Pubitemid 34539295)
30. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute pancreatitis, Atlanta, GA. September 11 through 13. Arch Surg 1993; 128:586-590.
31. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998; 42 (Suppl 2):1-13.
32. Aronson WL, Mc Auliffe MS, Miller K. Variability in the American society of anesthesiologists physical status classification scale. AANA J 2003; 71:265-274. (Pubitemid 36993453)
33. Berney T, Gasche Y, Robert J, Jenny A, Mensi N, Grau G, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 18: 371-377. (Pubitemid 29203310)
34. Altman DG. Practical Statistics for medical research. Chapman & Hall/CRC 1999. 15 Clinical trials 15.3 Sample size. 455-460.